このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

McPherson's マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Brett Charlton

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	less than a year
取締役会の平均在任期間	3.3yrs

経営陣の近況

Recent updates

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Dec 18

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

May 17

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

Feb 12

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 25

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

Jan 07

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Dec 20

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Dec 03

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

Nov 22

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Sep 10

Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks Like

Aug 19

McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up Surprises

Jul 30

Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 15

Should McPherson's Limited (ASX:MCP) Be Part Of Your Dividend Portfolio?

Jun 29

CEO（最高経営責任者

Brett Charlton

less than a year

在職期間

Mr. Brett Robert Charlton, B.Com., is Managing Director, Chief Executive Officer and Director at McPherson's Limited since August 01, 2023. He served as General Manager of Consumer Healthcare at Sanofi-ave...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Brett Charlton	MD, CEO & Director	less than a year	データなし	データなし
Mark Sherwin	Chief Financial Officer	less than a year	データなし	データなし
Nathan Alexander	Chief Information Officer	less than a year	データなし	データなし
Craig Durham	General Counsel & Company Secretary	less than a year	データなし	データなし
Donna Chan	Marketing Director	no data	データなし	データなし
Hanli Pretorius	Chief People Officer	less than a year	データなし	データなし
David Fielding	Director of Strategy	no data	データなし	データなし
Dawn Swainston	General Manager of Health	no data	データなし	データなし

0.4yrs

平均在職期間

経験豊富な経営陣: MCPの経営陣は経験豊富とはみなされません ( 0.4年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Brett Charlton	MD, CEO & Director	less than a year	データなし	データなし
Ari Mervis	Non-Executive Chairman	3.3yrs	AU$169.10k	0.10% A$ 63.0k
Alison Cook	Independent Non-Executive Director	5.9yrs	AU$137.32k	0.011% A$ 6.5k
Jane McKellar	Independent Non-Executive Director	9.3yrs	AU$99.10k	0.0080% A$ 4.8k
Helen Thornton	Independent Non-Executive Director	2.5yrs	AU$99.10k	0.014% A$ 8.4k

3.3yrs

平均在職期間

経験豊富なボード: MCPの取締役会は経験豊富であると考えられます ( 3.3年の平均在任期間)。

McPherson's マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

McPherson's Limited Announces Executive Changes

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Less than half of directors are independent

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

McPherson's Limited Appoints Linda Gough as Company Secretary

Recent updates

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Price target increased by 25% to AU$0.67

Upcoming dividend of AU$0.02 per share

New minor risk - Share price stability

McPherson's Limited Announces Executive Changes

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Here's Why McPherson's (ASX:MCP) Can Manage Its Debt Responsibly

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Price target decreased by 14% to AU$0.54

McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last Year

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Less than half of directors are independent

A Look At The Fair Value Of McPherson's Limited (ASX:MCP)

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

Consensus EPS estimates fall by 29%, revenue upgraded

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

Price target decreased by 7.9% to AU$0.78

Now 24% undervalued after recent price drop

First half 2023 earnings: EPS misses analyst expectations

Price target decreased by 11% to AU$0.84

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

Price target decreased to AU$0.84

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Consensus forecasts updated

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings: EPS misses analyst expectations

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$1.19

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Price target increased to AU$1.53

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Investor sentiment improved over the past week

McPherson's CEO Change

Market pulls back on stock over the past week

New 90-day low: AU$1.15

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Price target lowered to AU$2.36

Analysts lower EPS estimates to AU$0.083

Market pulls back on stock over the past week

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

New 90-day low: AU$2.18

Analysts update estimates

McPherson's Limited (ASX:MCP) entered into an agreement to acquire Global Therapeutics Pty Ltd from Blackmores Limited (ASX:BKL) for an enterprise value of AUD 27 million.

Analysts update estimates

New 90-day low: AU$2.64

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Independent Non-Executive Director recently bought AU$133k worth of stock

New 90-day high - AU$3.18

マネジメント基準チェック /14